These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6100228)

  • 1. On the role of dopamine receptors in aldosterone secretion.
    Frisina N; Buemi M; Macri' I
    Ann Endocrinol (Paris); 1984; 45(6):387-91. PubMed ID: 6100228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responses of plasma aldosterone, cortisol and adrenocorticotropin to two dopamine receptor antagonists.
    Staessen J; Fiocchi R; Bouillon R; Fagard R; Lijnen P; Lissens W; Amery A
    Methods Find Exp Clin Pharmacol; 1985 Oct; 7(10):523-7. PubMed ID: 3001453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G; Devilla L; Canessa A; D'Asta F
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
    J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine inhibits the aldosterone response to upright posture.
    Malchoff CD; Hughes J; Sen S; Jackson S; Carey RM
    J Clin Endocrinol Metab; 1986 Jul; 63(1):197-201. PubMed ID: 3519647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
    Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
    Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine selectively inhibits aldosterone responses to angiotensin II in man.
    Carey RM; Drake CR
    J Hypertens Suppl; 1984 Dec; 2(3):S267-9. PubMed ID: 6100739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the responses of plasma renin activity and aldosterone and cortisol levels to dopaminergic and opiate stimuli in man.
    Lightman SL
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):45-52. PubMed ID: 7030527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanism of action of metoclopramide-induced aldosterone secretion: in vivo and in vitro studies in the sheep.
    Wilson TA; Kaiser DL; Peach MJ; Wright EM; Carey RM
    Endocrinology; 1983 Sep; 113(3):887-92. PubMed ID: 6307670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
    Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
    Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.